Functional erythropoietin‐hepcidin axis in recombinant human erythropoietin independent haemodialysis patients-Reference-Cited by-同舟云学术

Functional erythropoietin‐hepcidin axis in recombinant human erythropoietin independent haemodialysis patients

Published:2019-04-25 Issue:7 Volume:24 Page:751-757
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Touzot Maxime¹,Lefebvre Thibaud²³,Roux Arthur¹,Maheas Catherine¹,Ridel Christophe¹,Puy Hervé²³,Karim Zoubida²³

Affiliation:

1. Aura Paris Plaisance, Dialysis and Apheresis Paris France

2. Institut National de Santé en Recherche Médicale (INSERM) U1149, centre de recherche sur l'inflammationCentre de recherche sur l'inflammation Paris France

3. Centre Français des PorphyriesHopîtal Louis Mourier Colombes France

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nep.13485

Reference35 articles.

1. Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function;Radtke HW;Blood,1979

2. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure

3. Anaemia management and mortality risk in chronic kidney disease

4. Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease

5. Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relation between erythropoietin resistance and metabolic syndrome in hemodialysis patients: A multicentric propensity score matched analysis;Journal of Investigative Medicine;2023-05-18

2. Factors associated with hepcidin‐25 levels in maintenance hemodialysis patients;Therapeutic Apheresis and Dialysis;2021-02-02

3. Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes;Clinical Kidney Journal;2020-09-07

4. A hepcidin‐based approach for iron therapy in hemodialysis patients: A pilot study;Hemodialysis International;2020-02-11